Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Cerebral Palsy Treatment Utilizes 2 Types of Autologous Stem Cells.

Posted by hunter@stemsave.com on Mar 31, 2015 10:41:58 AM

Researchers at the University Hospital Niño Jesus in Madrid, Spain, are conducting a clinical trial to determine the safety and efficacy of treating cerebral palsy patients with hematopoietic stem cells from cord blood, as well as mesenchymal stem cells [MSCs] from umbilical cord tissue.  The scientists will compare the two types of autologous [the patient’s own] stem cells in their effectiveness regarding immune-regulation, anti-inflammatory activity, and stimulation of brain tissue regeneration.

Read More

Topics: stemsaveblog, Brain, 'infantile' cerebral palsy, cerebral palsy, cord blood, clinical trial, Stem Cells Translational Medicine

Stem Cell-Based Medicinal Product Approved for Eye Damage Repair.

Posted by maxi@stemsave.com on Mar 27, 2015 12:30:00 PM

Italian scientists from the University of Modena and Holostem Terapie Avanzate have developed the first advanced therapy medicinal product containing stem cells, called Holoclar.  The Holoclar therapy can restore sight following corneal burns and stromal damage by harvesting the patient’s own stem cells from the limbus, culturing the stem cells into a sheet of healthy corneal tissue, and then transplanting the cornea back onto the patient’s eye.

Read More

Topics: stemsaveblog, corneal disease, Stem Cells Translational Medicine, macular degeneration, age-related macular degeneration, corneal burns,

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all